Quest Diagnostics is to introduce the new Simplexa Flu A/B & RSV Direct test in Europe.

The CE marked Simplexa Direct test will run on the 3M Integrated Cycler to detect influenza A and B and respiratory syncytial virus.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Developed by the Quest’s Focus Diagnostics business, it uses a proprietary technique to eliminate the nucleic acid sample-extraction process, allowing it to deliver results faster.